Adaptive Biotechnologies
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, Adaptive Biotechnologies sits in the upper quartile of US sponsors by registered trial count (#1,806 of 15,742 sponsors by registered trial count).
Adaptive Biotechnologies: 7 sponsored US clinical trials, 1 recruiting.
Adaptive Biotechnologies sponsors 7 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting, and 4 completed. The most-studied condition in this pipeline is Lyme Disease, with 1 trials.
Upper-quartile sponsor footprint
Adaptive Biotechnologies sits in the upper quartile of the sponsor corpus (#1,806 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Open and recent trials
7 total, page 1 of 1
Optimizing ctDNA-based MRD Assessment in DLBCL, MCL, and FL Patients Undergoing CAR Therapy
NCT05255354
ImmuneSense™ IBD Study
NCT05769829
ImmuneSense COVID-19 Variant Study
NCT05054088
The clonoSEQ® Watch Registry
NCT04545333
ImmuneSense™ COVID-19 Study
NCT04583982
ImmuneSense Lyme Study
NCT04422314
ImmuneRACE - Immune Response Action to COVID-19 Events
NCT04494893
Therapeutic Areas
What is open in the Adaptive Biotechnologies pipeline
1 recruiting of 7 indexed (14% open); 4 completed (57%).
Phase labels are sparse on this sponsor index, so phase mix is not charted here.
Top condition: Lyme Disease (1 trial), 3 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Adaptive Biotechnologies: open-pipeline peers nationwide
Peers matched on 7 registered trials and 14% open enrollment, not the therapeutic-area sidebar.
Adaptive Biotechnologies sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 7 trials (± recruiting share)
- 3M · 7 trials · 0% recruiting
- 4Life Research · 7 trials · 0% recruiting
- 89bio · 7 trials · 29% recruiting
- Abbott Diagnostics Division · 7 trials · 0% recruiting
Sponsors near 14% open enrollment (± trial volume)
- Academic and Community Cancer Research United · 14% recruiting · 42 trials
- AgelessRx · 14% recruiting · 7 trials
- Alaska Blind Child Discovery · 14% recruiting · 7 trials
- American College of Radiology · 14% recruiting · 14 trials
Related
What to do with this Adaptive Biotechnologies page
7 registered trials is a research-attention snapshot, not an endorsement of Adaptive Biotechnologies or any single study.
- 1 of Adaptive Biotechnologies's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Lyme Disease is the condition Adaptive Biotechnologies studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Lyme Disease trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Adaptive Biotechnologies pipeline card: 7 registered trials from official public datasets.Report a data error.